Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial

PURPOSE: We previously showed that a sequential chemotherapy with dose-dense oxaliplatin (FOLFOX7) and irinotecan (FOLFIRI; irinotecan plus 5-fluorouracil/leucovorin) is not superior to FOLFOX4 in patients at advanced stage of colorectal cancer with liver metastases. Here we aimed to determine wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamidou, Zeinab, Chibaudel, Benoist, Hebbar, Mohamed, Hug de Larauze, Marine, André, Thierry, Louvet, Christophe, Brusquant, David, Garcia-Larnicol, Marie-Line, de Gramont, Aimery, Bonnetain, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910973/
https://www.ncbi.nlm.nih.gov/pubmed/27310205
http://dx.doi.org/10.1371/journal.pone.0157067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910973/
https://www.ncbi.nlm.nih.gov/pubmed/27310205
http://dx.doi.org/10.1371/journal.pone.0157067

Ejemplares similares